|
|
|
|
최자윤 ( Choi Ja-Yun ) - 전남대학교 간호대학
오현정 ( Oh Hyeon-Jeong ) - 전남대학교 대학원 간호학과
강지영 ( Kang Ji-Young ) - 전남대학교 대학원 간호학과
김민경 ( Kim Min-Kyoung ) - 전남대학교 대학원 간호학과
김지은 ( Kim Ji-Eun ) - 전남대학교 대학원 간호학과
김진하 ( Kim Jin-Ha ) - 전남대학교 대학원 간호학과
김희숙 ( Kim Hee-Suk ) - 전남대학교 대학원 간호학과
박소라 ( Park So-Ra ) - 전남대학교 대학원 간호학과
변정선 ( Byun Jeong-Seon ) - 전남대학교 대학원 간호학과
안정희 ( An Jeong-Hee ) - 전남대학교 대학원 간호학과
조민경 ( Cho Min-Kyoung ) - 전남대학교 대학원 간호학과
|
|
Abstract
|
|
|
|
|
Purpose: The purpose of this study was to identify the compliance with the protocol, which was developed considering the emetogenic potential for prophylaxis of chemotherapy.
Methods: Data was collected from 144 patients who received chemotherapy from June 15 to August 31, 2010 in C University Hospital in Jeollanamdo, Korea. The level of chemotherapy-induced nausea and vomiting (CINV) and the compliance with the protocol for prophylaxis of CINV were measured.
Results: There was statistically significant difference of CINV in morning sickness and anticipatory nausea of general and clinical characteristics. Also, the compliance with the protocol developed according to emetogenic potential of chemotherapy was statistically significant. There was no difference in CINV in regard to the compliance with the protocol.
Conclusion: There was a good compliance with the protocol for prophylaxis according to emetogenic potential. But it should be recommended to use antiemetics for prophylaxis aggressively to relieve CINV for the patients who already experienced morning sickness and anticipatory nausea. In addition, the oncology nurses should respond sensitively to the complaints of nausea and vomiting no matter what the emetogenic potentials of chemotherapy regimen are.
|
|
|
KeyWords
|
|
프로토콜, 항암화화요법, 오심, 구토, 이행
Guideline Adherence, Antineoplastic combined chemotherapy protocols, Nausea, Vomiting
|
|
|
원문 및 링크아웃 정보
|
|
|
|
|
|
등재저널 정보
|
|
 
|
|
|
|
|